BDX stock icon

Becton Dickinson
BDX

$232.67
0.25%

Market Cap: $67.2B

 

About: Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2023 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.

Employees: 73,000

0
Funds holding %
of 6,686 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

36% more funds holding in top 10

Funds holding in top 10: 11 [Q1] → 15 (+4) [Q2]

5% more repeat investments, than reductions

Existing positions increased: 603 | Existing positions reduced: 576

0.57% less ownership

Funds ownership: 88.22% [Q1] → 87.65% (-0.57%) [Q2]

3% less call options, than puts

Call options by funds: $177M | Put options by funds: $183M

2% less funds holding

Funds holding: 1,564 [Q1] → 1,538 (-26) [Q2]

6% less capital invested

Capital invested by funds: $63.1B [Q1] → $59.4B (-$3.67B) [Q2]

19% less first-time investments, than exits

New positions opened: 108 | Existing positions closed: 134

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$255
10%
upside
Avg. target
$273
17%
upside
High target
$285
22%
upside

4 analyst ratings

positive
75%
neutral
25%
negative
0%
Raymond James
Jayson Bedford
73% 1-year accuracy
22 / 30 met price target
16%upside
$270
Outperform
Maintained
2 Aug 2024
Stifel
Rick Wise
68% 1-year accuracy
19 / 28 met price target
20%upside
$280
Buy
Maintained
26 Jul 2024
Citigroup
Joanna Wiensch
100% 1-year accuracy
2 / 2 met price target
10%upside
$255
Neutral
Maintained
10 Jul 2024
Evercore ISI Group
Vijay Kumar
90% 1-year accuracy
27 / 30 met price target
22%upside
$285
Outperform
Maintained
2 Jul 2024

Financial journalist opinion

Based on 10 articles about BDX published over the past 30 days